Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes.
Adolescent
Adult
Aged
Automation, Laboratory
Biomarkers
/ blood
CD11b Antigen
/ blood
Female
Flow Cytometry
/ instrumentation
Healthy Volunteers
Humans
Immunophenotyping
/ instrumentation
Leukocytes
/ immunology
Male
Middle Aged
Monocytes
/ immunology
Neprilysin
/ blood
Neutrophil Activation
Neutrophils
/ immunology
Phagocytes
/ immunology
Phenotype
Point-of-Care Systems
Point-of-Care Testing
Predictive Value of Tests
Receptors, Complement 3b
/ blood
Reproducibility of Results
Time Factors
Workflow
Young Adult
Activation antibodies
Fast analysis
Flow cytometry
Inflammatory cells
Phagocytes
Point-of-care
Journal
Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
27
05
2019
revised:
09
08
2019
accepted:
12
08
2019
pubmed:
17
8
2019
medline:
12
5
2020
entrez:
17
8
2019
Statut:
ppublish
Résumé
Phagocytes such as granulocytes and monocytes are fundamental players in the innate immune system. Activation of these cells can be quantified by the measurement of activation marker expression using flow cytometry. Analysis of receptor expression on inflammatory cells facilitates the diagnosis of inflammatory diseases and can be used to determine the extent of inflammation. However, several major limitations of this analysis precludes application of inflammation monitoring in clinical practice. Fast and automated analysis would minimalize ex vivo manipulation and allow reproducible processing. The aim of this study was to evaluate a fully automated "load & go" flow cytometer for analyzing activation of granulocytes and monocytes in a clinically applicable setting. Blood samples were obtained from 10 anonymous and healthy volunteers between the age of 18 and 65 years. Granulocyte and monocyte activation was determined by the use of the markers CD35, CD11b and CD10 measured in the automated AQUIOS CL® "load & go" flow cytometer. This machine is able to pierce the tube caps, add antibodies, lyse and measure the sample within 20 min after vena puncture. Reproducibility tests were performed to test the stability of activation marker expression on phagocytes. The expression of activation markers was measured at different time points after blood drawing to analyze the effect of bench time on granulocyte and monocyte activation. The duplicate experiments demonstrate a high reproducibility of the measurements of the activation state of phagocytes. Healthy controls showed a very homogenous expression of activation markers at T = 0 (immediately after vena puncture). Activation markers on neutrophils were already significantly increased after 1 h (T = 1) depicted as means (95%Cl) CD35: 2.2× (1.5×-2.5×) p = .028, CD11b: 2.5× (1.7×-3.1×) p = .023, CD10: 2.5× (2.1×-2.7×) p = .009) and a further increase in activation markers was observed after 2 and 3 h. Monocytes also showed a increase in activation markers in 1 h (mean (95%Cl) CD35: 1.8× (1.3×-2.2×) p = .058, CD11b: 2.13× (1.6×-2.4×) p = .025) and also a further significant increase in 2 and 3 h was observed. This study showed that bench time of one hour already leads to a significant upregulation and bigger variance in activation markers of granulocytes and monocytes. In addition, it is likely that automated flow cytometry reduces intra-assay variability in the analysis of activation markers on inflammatory cells. Therefore, we found that it is of utmost importance to perform immune activation analysis as fast as possible to prevent drawing wrong conclusions. Automated flow cytometry is able to reduce this analysis from 2 h to only 15-20 min without the need of dedicated personnel and in a point-of-care context. This now allows fast and automated inflammation monitoring in blood samples obtained from a variety of patient groups. FUND: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Identifiants
pubmed: 31419409
pii: S0022-1759(19)30210-8
doi: 10.1016/j.jim.2019.112646
pii:
doi:
Substances chimiques
Biomarkers
0
CD11b Antigen
0
CR1 protein, human
0
ITGAM protein, human
0
Receptors, Complement 3b
0
Neprilysin
EC 3.4.24.11
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112646Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.